Discordant immunological response in HIV-positive patients on non-nucleoside reverse transcriptase inhibitor-based regimens

VOGUE: Noninferior Efficacy of Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults With HIV-1 Naive to Treatment.

Open forum infectious diseases·2026

Risk of Developing Low-Level Viral Rebound Among People With HIV Receiving 2- or 3-Drug Regimens: A Case-Control Study Nested in the ICONA Cohort.

Open forum infectious diseases·2026

Healthcare Resource Consumption and Related Costs of People Living with HIV and Antiviral Treatment: A Retrospective Observational Study in Italy.

Diseases (Basel, Switzerland)·2026

96-week real-world effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in HIV-infected adults with pre-existing NRTI resistance: A retrospective cohort study.

Journal of global antimicrobial resistance·2025

Emergent HIV-1 Drug Resistance in Randomized Trials of Contemporary Antiretroviral Regimens.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025

Comparable gut mucosal breakdown and microbial translocation in severe COVID-19 with and without HIV infection.

AIDS (London, England)·2025

Efficacy of dolutegravir or bictegravir-containing therapy in a real-life cohort of people with HIV-1 sub-subtype A6.

AIDS (London, England)·2026

Sex-modulated associations between cytomegalovirus cell-associated DNA and cognition in people with HIV on ART.

AIDS (London, England)·2026

Clinical phenotypes and incidence of acute or recent hepatitis C virus infection and bacterial sexually transmitted infections among MSM with HIV.

AIDS (London, England)·2026

Long-term effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and resistance-associated mutations.

AIDS (London, England)·2026

Comparing carbon emissions from oral tenofovir disoproxil fumarate/emtricitabine for preexposure prophylaxis and long-acting injectables for HIV prevention.

AIDS (London, England)·2026

The additive value of coronary calcium in identifying cardiovascular risk in ageing people with HIV.

AIDS (London, England)·2026

CD86-Positive Mature Tertiary Lymphoid Structures Are Associated With CD8+ T-Cell Infiltration and Favorable Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.

Annals of gastroenterological surgery·2026

Bridging the Gap: Measles Susceptibility and Neutralization Test-Confirmed Immunity in a Spanish HIV-PrEP Cohort.

Open forum infectious diseases·2026

Prevalence of neutralizing autoantibodies against type I interferon in dengue patients.

Journal of human immunity·2026

Spatial niche remodeling of senescent liver-resident immune cells and its role in chronic liver diseases.

Frontiers in medicine·2026

IL1RAP Is Associated With an Inflammation-Immunity-Related State in Skin Cutaneous Melanoma: Integrative Evidence From Pan-Cancer Data and Melanoma Immunotherapy Cohorts.

International journal of genomics·2026

Mitochondrial checkpoint for interferon responses in macrophages.

Exploration of targeted anti-tumor therapy·2026

Related Experiment Videos

Discordant immunological response in HIV-positive patients on non-nucleoside reverse transcriptase inhibitor-based

Related Concept Videos

VOGUE: Noninferior Efficacy of Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults With HIV-1 Naive to Treatment.

Risk of Developing Low-Level Viral Rebound Among People With HIV Receiving 2- or 3-Drug Regimens: A Case-Control Study Nested in the ICONA Cohort.

Healthcare Resource Consumption and Related Costs of People Living with HIV and Antiviral Treatment: A Retrospective Observational Study in Italy.

96-week real-world effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in HIV-infected adults with pre-existing NRTI resistance: A retrospective cohort study.

Emergent HIV-1 Drug Resistance in Randomized Trials of Contemporary Antiretroviral Regimens.

Comparable gut mucosal breakdown and microbial translocation in severe COVID-19 with and without HIV infection.

Efficacy of dolutegravir or bictegravir-containing therapy in a real-life cohort of people with HIV-1 sub-subtype A6.

Sex-modulated associations between cytomegalovirus cell-associated DNA and cognition in people with HIV on ART.

Clinical phenotypes and incidence of acute or recent hepatitis C virus infection and bacterial sexually transmitted infections among MSM with HIV.

Long-term effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and resistance-associated mutations.

Comparing carbon emissions from oral tenofovir disoproxil fumarate/emtricitabine for preexposure prophylaxis and long-acting injectables for HIV prevention.

The additive value of coronary calcium in identifying cardiovascular risk in ageing people with HIV.

CD86-Positive Mature Tertiary Lymphoid Structures Are Associated With CD8+ T-Cell Infiltration and Favorable Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.

Bridging the Gap: Measles Susceptibility and Neutralization Test-Confirmed Immunity in a Spanish HIV-PrEP Cohort.

Prevalence of neutralizing autoantibodies against type I interferon in dengue patients.

Spatial niche remodeling of senescent liver-resident immune cells and its role in chronic liver diseases.

IL1RAP Is Associated With an Inflammation-Immunity-Related State in Skin Cutaneous Melanoma: Integrative Evidence From Pan-Cancer Data and Melanoma Immunotherapy Cohorts.

Mitochondrial checkpoint for interferon responses in macrophages.

Related Experiment Videos

Discordant immunological response in HIV-positive patients on non-nucleoside reverse transcriptase inhibitor-based...

Related Concept Videos

Related Articles

Discordant immunological response in HIV-positive patients on non-nucleoside reverse transcriptase inhibitor-based